Design
Review
Authors
Loading...
Supports arterial MRI for trial surrogates; leaves open routine clinical adoption pending prospective data.
MRI of the arterial wall is a viable technology for characterizing atherosclerotic lesion size, composition, and biological activity, potentially serving as a surrogate endpoint in clinical trials.
Yuan et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: